Hims & Hers Health is trading 5.8% down at €24.70, with broad risk-off pressure from rising oil prices and elevated Treasury yields weighing on equities.
- Healthcare stocks also declined; sector context cited broad market and geopolitical concerns—not a company-specific development—as the main pressure.
- Coverage noted an accounting leadership transition and ongoing litigation-related concerns, but did not establish either as the direct cause of the decline.